We are live on ! Find out more
CB

Christopher Bloomstran Semper Augustus Investments Group

AUM $885M
1-Year Est. Return 30.72%
 

Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.

This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+30.72%
3 Year Est. Return
+95.38%
5 Year Est. Return
+117.62%
10 Year Est. Return
+411.84%
AUM
$156M
AUM Growth
-$17.7M
Cap. Flow
-$7.16M
Cap. Flow %
-4.6%
Top 10 Hldgs %
73.93%
Holding
29
New
Increased
1
Reduced
22
Closed
1

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$1.76M

Sector Composition

Rank Sector Weight
1 Financials 49.24%
2 Materials 12.02%
3 Consumer Discretionary 8.99%
4 Industrials 7.91%
5 Consumer Staples 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
26
GE Aerospace
GE
$361B
$904K 0.58%
24,917
-21
-0.1% -$948
MDT icon
27
Medtronic
MDT
$119B
$459K 0.29%
5,050
RDS.A
28
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$284K 0.18%
4,868
SNY icon
29
Sanofi
SNY
$110B
-123,472
Closed -$5.51M

Similar funds

Christopher Bloomstran's Q4 2018 Portfolio in Review

As of Q4 2018, Christopher Bloomstran held 29 positions worth $156M, down 10% from $173M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Christopher Bloomstran withdrew a net $7.16M in Q4 2018, closing 1 position and reducing 22 holdings. Its most notable exit was Sanofi, an estimated $5.51M position sold in full.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 47% a quarter earlier, followed by Materials and Consumer Discretionary.

Against the trend, Christopher Bloomstran added an estimated $1.76M to NXP Semiconductors.

  • Christopher Bloomstran added most to NXP Semiconductors in Q4 2018, an estimated $1.76M increase.
  • Christopher Bloomstran's biggest Q4 2018 reduction was Usg, cutting an estimated $758K.
  • Christopher Bloomstran fully exited Sanofi in Q4 2018, selling an estimated $5.51M.
  • Christopher Bloomstran's ten largest holdings make up 74% of its $156M portfolio in Q4 2018.
  • Christopher Bloomstran opened 0 new positions and closed 1 in Q4 2018.
  • Christopher Bloomstran's portfolio value fell 10% quarter-over-quarter to $156M.

Based on Semper Augustus Investments Group's 13F filing for Q4 2018, filed 13 Feb 2019.